City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
   
The following is a list of available studies directed by  Sanjeet Dadwal, MD  
Search results:  1  Clinical trial(s) found  (Page 1 of 1 )
 
Click here to generate a printer-friendly view  
 09015
   P.I.: Sanjeet Dadwal, MD (Industrial)
Title: A Phase I/IIa Randomized, Observer-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Immunogenicity of the GSK Biologicals' Herpes Zoster Vaccine, gE/AS01B, in Comparison to gE Combined With 1/2 Dose AS01B Adjuvant (gE/AS01E) and to Saline (Placebo) When Administered as 2 Doses or 3 Doses to Autologous Hematopoietic Stem Cell Transplantation (HCT) Recipients.
 
Click here for  Full Eligibility Criteria
 

  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and urology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.